Monoclonal antibody therapy of adult acute lymphoblastic leukemia: progress and challenge for new clinical trials
Drugs and Cell Therapies in Hematology(2013)
Abstract
SUMMARY Monoclonal antibody therapy for adult acute lymphoblastic leukemia is an emerging therapeutic option which offers substantial opportunities to improve treatment results. The evidence in favor of this approach is presented as a challenge to develop new clinical trials and extend the therapeutic benefit to all patient and disease subsets.
MoreTranslated text
Key words
monoclonal antibody
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined